(Q44306302)

1 December 2017

Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques (English)

1 reference

1 December 2017

2

1 reference

1 December 2017

Mark P Burns

1

0 references

author name string

Vicki Olm

3

1 reference

1 December 2017

Kate Gaynor

4

1 reference

1 December 2017

Evelyn Casey

5

1 reference

1 December 2017

John LaFrancois

6

1 reference

1 December 2017

Lili Wang

7

1 reference

1 December 2017

Karen Duff

8

1 reference

1 December 2017

language of work or name

1 reference

1 January 2003

1 reference

1 December 2017

Molecular Brain Research

1 reference

1 December 2017

110

1 reference

1 December 2017

119-125

1 reference

1 December 2017

1

1 reference

Lipid binding to amyloid beta-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Lipoprotein uptake by neuronal growth cones in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(SW) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Statin therapy for Alzheimer's disease: will it work?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900647-2

7 January 2021

10.1016/S0169-328X(02)00647-2

Identifiers

DOI

1 reference

1 December 2017

1 reference